Year |
Citation |
Score |
2023 |
Jo J, Kim J, Ibrahim L, Kumar M, Iaconelli J, So Tran C, Ryong Moon H, Jung Y, Luke Wiseman R, Lairson LL, Chatterjee AK, Bollong MJ, Yun H. Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators. Bioorganic & Medicinal Chemistry Letters. 129306. PMID 37116763 DOI: 10.1016/j.bmcl.2023.129306 |
0.778 |
|
2022 |
Lee SM, Kim CE, Park HY, Yoon EH, Won HJ, Ahn JM, Nguyen NZN, Kim M, Jang WH, Lee WS, Kang MS, Jeong M, Yun H, Park S, Wu S, et al. Aryl hydrocarbon receptor-targeted therapy of CD4+ T-cell-mediated idiopathic pneumonia syndrome in mice. Blood. PMID 35226727 DOI: 10.1182/blood.2021013849 |
0.308 |
|
2021 |
Song K, Rajasekaran N, Chelakkot C, Lee HS, Paek SM, Yang H, Jia L, Park HG, Son WS, Kim YJ, Choi JS, Jeong HM, Suh YG, Yun H, Shin YK. Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH. Pharmaceuticals (Basel, Switzerland). 14. PMID 34681284 DOI: 10.3390/ph14101060 |
0.313 |
|
2021 |
Lee SC, Ma JSY, Kim MS, Laborda E, Choi SH, Hampton EN, Yun H, Nunez V, Muldong MT, Wu CN, Ma W, Kulidjian AA, Kane CJ, Klyushnichenko V, Woods AK, et al. A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand. Science Advances. 7. PMID 34380625 DOI: 10.1126/sciadv.abi8193 |
0.778 |
|
2021 |
Cao YJ, Wang X, Wang Z, Zhao L, Li S, Zhang Z, Wei X, Yun H, Choi SH, Liu Z, Zhao L, Kazane SA. Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers. Acs Synthetic Biology. PMID 33856201 DOI: 10.1021/acssynbio.1c00007 |
0.8 |
|
2021 |
Jo J, Ibrahim L, Iaconelli J, Kwak J, Kumar M, Jung Y, Lairson LL, Chatterjee AK, Schultz PG, Bollong MJ, Yun H. Discovery and SAR studies of 3-amino-4-(phenylsulfonyl)tetrahydrothiophene 1,1-dioxides as non-electrophilic antioxidant response element (ARE) activators. Bioorganic Chemistry. 108: 104614. PMID 33508678 DOI: 10.1016/j.bioorg.2020.104614 |
0.773 |
|
2019 |
Jo J, Kim H, Oh JY, Kim S, Park YH, Choi H, Jeong JY, Jung YS, Yun H. SAR optimization studies on a novel series of 2-anilinopyrimidines as selective inhibitors against triple-negative breast cancer cell line MDA-MB-468. Bioorganic & Medicinal Chemistry Letters. 126752. PMID 31711784 DOI: 10.1016/J.Bmcl.2019.126752 |
0.363 |
|
2019 |
Jo J, Jeong M, Ahn JS, Akter J, Kim HS, Suh YG, Yun H. Total Synthesis of Anmindenol A and Its Application to the Design, Synthesis, and Biological Evaluation of Derivatives Thereof. The Journal of Organic Chemistry. PMID 31357857 DOI: 10.1021/Acs.Joc.9B01564 |
0.353 |
|
2018 |
Jo J, Kim SH, Kim H, Jeong M, Kwak JH, Taek Han Y, Jeong JY, Jung YS, Yun H. Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468. Bioorganic & Medicinal Chemistry Letters. PMID 30447889 DOI: 10.1016/J.Bmcl.2018.11.010 |
0.359 |
|
2018 |
Ahn SY, Jo MS, Lee D, Baek SE, Baek J, Yu JS, Jo J, Yun H, Kang KS, Yoo JE, Kim KH. Dual effects of isoflavonoids from Pueraria lobata roots on estrogenic activity and anti-proliferation of MCF-7 human breast carcinoma cells. Bioorganic Chemistry. 83: 135-144. PMID 30352359 DOI: 10.1016/J.Bioorg.2018.10.017 |
0.36 |
|
2018 |
Bollong MJ, Lee G, Coukos JS, Yun H, Zambaldo C, Chang JW, Chin EN, Ahmad I, Chatterjee AK, Lairson LL, Schultz PG, Moellering RE. A metabolite-derived protein modification integrates glycolysis with KEAP1-NRF2 signalling. Nature. PMID 30323285 DOI: 10.1038/S41586-018-0622-0 |
0.719 |
|
2018 |
Jung JW, Kim NJ, Yun H, Han YT. Recent Advances in Synthesis of 4-Arylcoumarins. Molecules (Basel, Switzerland). 23. PMID 30241375 DOI: 10.3390/Molecules23102417 |
0.613 |
|
2017 |
Ahn J, Lim C, Yun H, Kim HS, Kwon S, Lee J, Lee S, An H, Park HG, Suh YG. Asymmetric Total Synthesis of (+)-Intricenyne via an Endocyclization Route to Oxocane Skeleton. Organic Letters. 19: 6642-6645. PMID 29192789 DOI: 10.1021/Acs.Orglett.7B03370 |
0.308 |
|
2017 |
Lee SM, Park HY, Suh YS, Yoon EH, Kim J, Jang WH, Lee WS, Park SG, Choi IW, Choi I, Kang SW, Yun H, Teshima T, Kwon B, Seo SK. Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway. Proceedings of the National Academy of Sciences of the United States of America. PMID 28673995 DOI: 10.1073/Pnas.1615280114 |
0.345 |
|
2016 |
Cao Y, Rodgers DT, Du J, Ahmad I, Hampton EN, Ma JS, Mazagova M, Choi SH, Yun HY, Xiao H, Yang P, Luo X, Lim RK, Pugh HM, Wang F, et al. Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer. Angewandte Chemie (International Ed. in English). 55: 7520-4. PMID 27145250 DOI: 10.1002/Anie.201601902 |
0.722 |
|
2016 |
Ma JS, Kim JY, Kazane SA, Choi SH, Yun HY, Kim MS, Rodgers DT, Pugh HM, Singer O, Sun SB, Fonslow BR, Kochenderfer JN, Wright TM, Schultz PG, Young TS, et al. Versatile strategy for controlling the specificity and activity of engineered T cells. Proceedings of the National Academy of Sciences of the United States of America. 113: E450-8. PMID 26759368 DOI: 10.1073/Pnas.1524193113 |
0.761 |
|
2015 |
Bollong MJ, Yun H, Sherwood L, Woods AK, Lairson LL, Schultz PG. A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer. Acs Chemical Biology. 10: 2193-8. PMID 26270491 DOI: 10.1021/Acschembio.5B00448 |
0.78 |
|
2015 |
Kim MS, Ma JS, Yun H, Cao Y, Kim JY, Chi V, Wang D, Woods A, Sherwood L, Caballero D, Gonzalez J, Schultz PG, Young TS, Kim CH. Redirection of genetically engineered CAR-T cells using bifunctional small molecules. Journal of the American Chemical Society. 137: 2832-5. PMID 25692571 DOI: 10.1021/Jacs.5B00106 |
0.805 |
|
2014 |
Yun H, Sim J, An H, Lee J, Lee HS, Shin YK, Paek SM, Suh YG. Design and synthesis of a macrosphelide A-biotin chimera. Organic & Biomolecular Chemistry. 12: 7127-35. PMID 25098405 DOI: 10.1039/C4Ob01028K |
0.37 |
|
2014 |
Kim K, Maharjan S, Lim C, Kim NJ, Agrawal V, Han YT, Lee S, An H, Yun H, Choi HJ, Kwon YG, Suh YG. Glucal-conjugated sterols as novel vascular leakage blocker: structure-activity relationship focusing on the C17-side chain. European Journal of Medicinal Chemistry. 75: 184-94. PMID 24531231 DOI: 10.1016/J.Ejmech.2014.01.027 |
0.611 |
|
2014 |
Chun SK, Jang J, Chung S, Yun H, Kim NJ, Jung JW, Son GH, Suh YG, Kim K. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. Acs Chemical Biology. 9: 703-10. PMID 24387302 DOI: 10.1021/Cb400752K |
0.628 |
|
2013 |
Kim CH, Axup JY, Lawson BR, Yun H, Tardif V, Choi SH, Zhou Q, Dubrovska A, Biroc SL, Marsden R, Pinstaff J, Smider VV, Schultz PG. Bispecific small molecule-antibody conjugate targeting prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: 17796-801. PMID 24127589 DOI: 10.1073/Pnas.1316026110 |
0.762 |
|
2013 |
Seo H, Yun H, Lee S, Jang J, Han YT, Kim DD, Lee J, Suh YG. Stereoselective synthesis of 7-epi-incarvilline. Organic Letters. 15: 531-3. PMID 23343424 DOI: 10.1021/Ol303395F |
0.315 |
|
2013 |
Kim NJ, Li FN, Lee JH, Park SG, Kim K, Lim C, Han YT, Yun H, Jung JW, Park HG, Kim HD, Woo BY, Shin SS, Kim SY, Choi JK, et al. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities. Chemistry, An Asian Journal. 8: 400-9. PMID 23208797 DOI: 10.1002/Asia.201200730 |
0.623 |
|
2012 |
Chang DJ, An H, Kim KS, Kim HH, Jung J, Lee JM, Kim NJ, Han YT, Yun H, Lee S, Lee G, Lee S, Lee JS, Cha JH, Park JH, et al. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis. Journal of Medicinal Chemistry. 55: 10863-84. PMID 23186287 DOI: 10.1021/Jm301488Q |
0.654 |
|
2012 |
Han YT, Choi GI, Son D, Kim NJ, Yun H, Lee S, Chang DJ, Hong HS, Kim H, Ha HJ, Kim YH, Park HJ, Lee J, Suh YG. Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors. Journal of Medicinal Chemistry. 55: 9120-35. PMID 22742537 DOI: 10.1021/Jm300172Z |
0.614 |
|
2012 |
Suh YG, Lee YS, Kim SH, Jung JK, Yun H, Jang J, Kim NJ, Jung JW. A stereo-controlled access to functionalized macrolactams via an aza-Claisen rearrangement. Organic & Biomolecular Chemistry. 10: 561-8. PMID 22108849 DOI: 10.1039/C1Ob06733H |
0.6 |
|
2012 |
Sim J, Yun H, Jung J, Lee S, Kim N, Suh Y. Achiral auxiliary-assisted chiral transfer via microwave-accelerated aza-Claisen rearrangement: a short synthesis of (+)-1-hydroxyquinolizidinone Tetrahedron Letters. 53: 4813-4815. DOI: 10.1016/J.Tetlet.2012.06.073 |
0.594 |
|
2011 |
Han YT, Kim NJ, Jung JW, Yun H, Lee S, Suh YG. A versatile synthetic approach to grandisol monoterpene pheromone. Archives of Pharmacal Research. 34: 1437-42. PMID 21975804 DOI: 10.1007/S12272-011-0904-7 |
0.591 |
|
2011 |
Lee S, Paek SM, Yun H, Kim NJ, Suh YG. Enantioselective total synthesis of a natural iridoid. Organic Letters. 13: 3344-7. PMID 21619009 DOI: 10.1021/Ol201089F |
0.599 |
|
2010 |
Kim NJ, Moon H, Park T, Yun H, Jung JW, Chang DJ, Kim DD, Suh YG. Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). The Journal of Organic Chemistry. 75: 7458-60. PMID 20929274 DOI: 10.1021/Jo101523K |
0.587 |
|
2009 |
Yun H, Paek SM, Jung JW, Kim NJ, Kim SH, Suh YG. First total syntheses of (-)-macrosphelides J and K and elucidation of their absolute configuration. Chemical Communications (Cambridge, England). 2463-5. PMID 19532857 DOI: 10.1039/B817693K |
0.559 |
|
2009 |
Paek SM, Yun H, Kim NJ, Jung JW, Chang DJ, Lee S, Yoo J, Park HJ, Suh YG. Concise syntheses of (+)-macrosphelides A and B: studies on the macro-ring closure strategy. The Journal of Organic Chemistry. 74: 554-61. PMID 19086801 DOI: 10.1021/Jo8016692 |
0.599 |
|
Show low-probability matches. |